Research News

Regeneron Pharmaceuticals, Inc. and Sanofi presented positive results from the EVEREST Phase 4 trial in adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting asthma. In the trial, Dupixent.

Roche announced today its decision to proceed with Phase III development of prasinezumab, an investigational anti-alpha-synuclein antibody, in early-stage Parkinson’s disease.

Looking to nature for answers to complex questions can reveal new and unprecedented results that can even affect cells on molecular levels.

Sea cucumbers are the ocean's janitors, cleaning the seabed and recycling nutrients back into the water. But this humble marine invertebrate could also hold the key to stopping the spread of cancer.

A new study published in the journal Diabetes, Obesity and Metabolism has found that sodium-glucose co-transporter-2 (SGLT2) inhibitors are associated with a reduced incidence of atrial fibrillation in patients with type 2 diabetes mellitus.

The mammalian liver has an extraordinary regenerative capacity, capable of fully restoring its mass and function after injury or partial resection. A study led by researchers at the University of Barcelona has identified the DNA regions that activate the regeneration of this organ.

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study by researchers at University of Pittsburgh School of Public Health and the Pennsylvania State University. The study was published today in NPJ Vaccines.

Dapagliflozin shows promise in treating metabolic dysfunction-associated steatohepatitis (MASH), with or without type 2 diabetes in a new clinical trial conducted in China.